BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan T, Han D, Xu Y, Peng W, Bai L, Zhou X, He H. LC-MS Based Metabolomics Study of the Effects of EGCG on A549 Cells. Front Pharmacol 2021;12:732716. [PMID: 34650434 DOI: 10.3389/fphar.2021.732716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xue Z, Zeng J, Yin X, Li Y, Meng B, Zhao Y, Fang X, Gong X, Dai X. Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis. Front Mol Biosci 2023;10:1116398. [PMID: 36743215 DOI: 10.3389/fmolb.2023.1116398] [Reference Citation Analysis]
2 Zhang L, Wen JX, Hai L, Wang YF, Yan L, Gao WH, Hu ZD, Wang YJ. Preventive and therapeutic effects of green tea on lung cancer: a narrative review of evidence from clinical and basic research. J Thorac Dis 2022;14:5029-38. [PMID: 36647481 DOI: 10.21037/jtd-22-1791] [Reference Citation Analysis]
3 Xu G, Xue W, Zhang D, Yu Z, Liu J, Zhao W. Non-targeted cellular metabolomics revealing the metabolomic features and anti-tumor mechanisms of cyanidin-3-O-arabinoside on Caco-2 cells. Food Bioscience 2022. [DOI: 10.1016/j.fbio.2022.102296] [Reference Citation Analysis]
4 Liu Q, Shen J, Hong H, Yang Q, Liu W, Guan Z, Wang Y, Chen X. Cell metabolomics study on the anticancer effects of Ophiopogon japonicus against lung cancer cells using UHPLC/Q-TOF-MS analysis. Front Pharmacol 2022;13:1017830. [DOI: 10.3389/fphar.2022.1017830] [Reference Citation Analysis]
5 He H, Pan T, Shi X, Yang S, Jasbi P, Jin Y, Cui JY, Gu H. An integrative cellular metabolomic study reveals downregulated tricarboxylic acid cycle and potential biomarkers induced by tetrabromobisphenol A in human lung A549 cells. Environmental Toxicology. [DOI: 10.1002/tox.23657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lv M, Liang Q, Luo Z, Han B, Ni T, Wang Y, Tao L, Lyu W, Xiang J, Liu Y. UPLC-LTQ-Orbitrap-Based Cell Metabolomics and Network Pharmacology Analysis to Reveal the Potential Antiarthritic Effects of Pristimerin: In Vitro, In Silico and In Vivo Study. Metabolites 2022;12:839. [DOI: 10.3390/metabo12090839] [Reference Citation Analysis]